Keep in mind that results may differ from person to person
Ozempic (semaglutide injection, 0.52 mg) is FDA-approved to improve blood sugar control in adults with type 2 diabetes and to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established heart disease
Participants showed significant improvements in waist circumference, blood pressure, triglycerides, and markers of insulin resistance
It converts a dose you enter into units
On average, people lose about 5% to 7% of their body weight within the first 3 months, depending on the dose
Terushkin , a board-certified, fellowship-trained surgeon with over a decade of experience, were dedicated to providing you with accurate, comprehensive information to empower your health decisions